WallStreetZenWallStreetZen

NASDAQ: ELVN
Enliven Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Enliven Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ELVN annual revenue was $0.0, with N/A growth year-over-year.

ELVN revenue history

Current Revenue
$0.0
Current Earnings
-$89.0M
Current Profit Margin
0%

Be the first to know when ELVN announces revenue.

ELVN Revenue History By Year

ELVN Yearly RevenueELVN RevenueELVN ChangeELVN Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A

1 of 1

Enliven Therapeutics Revenue FAQ

What was ELVN's revenue last quarter?

On Invalid Date, Enliven Therapeutics (NASDAQ: ELVN) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Enliven Therapeutics's revenue was $0.00.

What was Enliven Therapeutics's revenue in 2024?

Enliven Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Enliven Therapeutics make in a day?

Based on Enliven Therapeutics annual revenue for the past five years, ELVN makes an average of $0.00 per day.

What was Enliven Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Enliven Therapeutics's revenue has grown null year over year. Enliven Therapeutics's revenue in the past year totaled $0.00.

How much does Enliven Therapeutics make in a year?

Enliven Therapeutics's revenue by year for the past five years is:
  • Enliven Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Enliven Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Enliven Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Enliven Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Enliven Therapeutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.